{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:56:43Z","timestamp":1792796203411,"version":"4.5.0"},"reference-count":101,"publisher":"Maad Rayan Publishing Company","issue":"1","content-domain":{"domain":["journals.tbzmed.ac.ir"],"crossmark-restriction":true},"short-container-title":["Adv Pharm Bull"],"DOI":"10.15171\/apb.2017.004","type":"journal-article","created":{"date-parts":[[2017,4,23]],"date-time":"2017-04-23T15:38:50Z","timestamp":1492961930000},"page":"21-34","update-policy":"https:\/\/doi.org\/10.15171\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The Challenges of Recombinant Endostatin in Clinical Application: Focus on the Different Expression Systems and Molecular Bioengineering"],"prefix":"10.34172","volume":"7","author":[{"given":"Abbas","family":"Mohajeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarvin","family":"Sanaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Kiafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Fattahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosratollah","family":"Zarghami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"20123","published-online":{"date-parts":[[2017,4,13]]},"reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1021\/jm5019252"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2005.11.015"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2015\/12016.6135"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2015.73"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12344"},{"key":"R6","doi-asserted-by":"publisher","first-page":"713\u200f","DOI":"10.1016\/S1470-2045(03)01292-0","article-title":"Australia approves thalidomide","volume":"4","author":"Habeck M","year":"2003","journal-title":"Lancet Oncol"},{"key":"R7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1084\/jem.141.2.427","article-title":"Inhibition of tumor angiogenesis mediated by cartilage","volume":"141","author":"Brem H","year":"1975","journal-title":"J Exp Med"},{"key":"R8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1615\/CritRevEukaryotGeneExpr.v12.i3.20","article-title":"Cellular actions and signaling by endostatin","volume":"12","author":"Ramchandran R","year":"2002","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"R9","first-page":"2883","article-title":"Comparison of the effects of recombinant human endostatin and docetaxel on human umbilical vein endothelial cells in different growth states","volume":"124","author":"Xu WJ","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700530"},{"key":"R11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: An endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O'Reilly MS","year":"1997","journal-title":"Cell"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.3390\/ph3103021"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(05)94005-0"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1080\/15216540211466"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.15.4249"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.6.1656"},{"key":"R17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2174\/138920308784534050","article-title":"Research advances of endostatin and its short internal fragments","volume":"9","author":"Xu HL","year":"2008","journal-title":"Curr Protein Pept Sci"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.2000.3553"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.22.6240"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2007.05.058"},{"key":"R21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0014-5793(97)01503-2","article-title":"Isolation and characterization of the circulating form of human endostatin","volume":"420","author":"Standker L","year":"1997","journal-title":"FEBS Lett"},{"key":"R22","doi-asserted-by":"publisher","first-page":"10443","DOI":"10.1073\/pnas.95.18.10443","article-title":"Zinc-dependent dimers observed in crystals of human endostatin","volume":"95","author":"Ding YH","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M309868200"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.9617"},{"key":"R25","first-page":"191","article-title":"N-\/c-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent","volume":"11","author":"Cho H","year":"2004","journal-title":"Oncol Rep"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1833"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2172"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.367"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2007.12.011"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1007\/s000180050171"},{"key":"R31","doi-asserted-by":"publisher","first-page":"11721","DOI":"10.1074\/jbc.274.17.11721","article-title":"Endostatin induces endothelial cell apoptosis","volume":"274","author":"Dhanabal M","year":"1999","journal-title":"J Biol Chem"},{"key":"R32","first-page":"411","article-title":"Endostar induces apoptotic effects in huvecs through activation of caspase-3 and decrease of bcl-2","volume":"29","author":"Ling Y","year":"2009","journal-title":"Anticancer Res"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.01.123"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.110.223750"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107463"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.10.5522"},{"key":"R37","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1182\/blood.V95.11.3403","article-title":"Endostatin-induced tyrosine kinase signaling through the shb adaptor protein regulates endothelial cell apoptosis","volume":"95","author":"Dixelius J","year":"2000","journal-title":"Blood"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M100743200"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-01-064428"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1002\/iub.215"},{"key":"R41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1134\/S0006297907030017","article-title":"Endostatin: Current concepts about its biological role and mechanisms of action","volume":"72","author":"Digtyar AV","year":"2007","journal-title":"Biochemistry (Mosc)"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M202771200"},{"key":"R43","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1096\/fj.99-1083com","article-title":"Antiangiogenesis signals by endostatin","volume":"15","author":"Shichiri M","year":"2001","journal-title":"FASEB J"},{"key":"R44","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0014-5793(02)02742-4","article-title":"Endostatin binds to the catalytic domain of matrix metalloproteinase-2","volume":"519","author":"Lee SJ","year":"2002","journal-title":"FEBS Lett"},{"key":"R45","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S1097-2765(04)00102-9","article-title":"Endostatin's antiangiogenic signaling network","volume":"13","author":"Abdollahi A","year":"2004","journal-title":"Mol Cell"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.15171\/apb.2016.026\u200f"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2009.47"},{"key":"R48","first-page":"1947","article-title":"Endostatin derivative angiogenesis inhibitors","volume":"122","author":"Zheng MJ","year":"2009","journal-title":"Chin Med J (Engl)"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1038\/37126"},{"key":"R50","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-010-0122-9"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.1186\/1556-276X-7-666"},{"key":"R52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0167-8140(02)00280-3","article-title":"Gene therapy delivery of endostatin enhances the treatment efficacy of radiation","volume":"66","author":"Shi W","year":"2003","journal-title":"Radiother Oncol"},{"key":"R53","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-10-14"},{"key":"R54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.01.086"},{"key":"R55","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25932"},{"key":"R56","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2009.01.008"},{"key":"R57","doi-asserted-by":"publisher","DOI":"10.1016\/j.pep.2004.01.003"},{"key":"R58","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0958-1669(99)80027-5","article-title":"Large-scale transient expression in mammalian cells for recombinant protein production","volume":"10","author":"Wurm F","year":"1999","journal-title":"Curr Opin Biotechnol"},{"key":"R59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0734-9750(91)90404-J","article-title":"Production scale insect cell culture","volume":"9","author":"Agathos SN","year":"1991","journal-title":"Biotechnol Adv"},{"key":"R60","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005510821928"},{"key":"R61","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1290\/1071-2690(2001)037<0005:OPAIVA>2.0.CO;2","article-title":"Optimal production and in vitro activity of recombinant endostatin from stably transformed drosophila melanogaster s2 cells","volume":"37","author":"Park JH","year":"2001","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"R62","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0734-9750(92)90002-Q","article-title":"High-level expression of foreign genes in hansenula polymorpha","volume":"10","author":"\u200fGellissen G","year":"1992","journal-title":"Biotechnol Adv"},{"key":"R63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0931263100"},{"key":"R64","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.0595"},{"key":"R65","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0931263100"},{"key":"R66","doi-asserted-by":"publisher","DOI":"10.1002\/bit.10587"},{"key":"R67","doi-asserted-by":"publisher","DOI":"10.5897\/AJB05.309\u200f"},{"key":"R68","doi-asserted-by":"publisher","DOI":"10.1023\/A:1020357732474"},{"key":"R69","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S1046-5928(02)00526-0","article-title":"Synonymous codon usage bias and the expression of human glucocerebrosidase in the methylotrophic yeast, pichia pastoris","volume":"26","author":"Sinclair G","year":"2002","journal-title":"Protein Expr Purif"},{"key":"R70","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1046-5928(02)00560-0","article-title":"Expression and characterization of a synthetic protein c activator in pichia pastoris","volume":"26","author":"Kunes YZ","year":"2002","journal-title":"Protein Expr Purif"},{"key":"R71","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-006-0604-2"},{"key":"R72","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.4014\/jmb.1004.04040","article-title":"The orientation-dependent expression of angiostatin-endostatin hybrid proteins and their characterization for the synergistic effects of antiangiogenesis","volume":"20","author":"Paek SY","year":"2010","journal-title":"J Microbiol Biotechnol"},{"key":"R73","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s002530050651","article-title":"Foreign gene expression in hansenula polymorpha. A system for the synthesis of small functional peptides","volume":"45","author":"Faber KN","year":"1996","journal-title":"Appl Microbiol Biotechnol"},{"key":"R74","doi-asserted-by":"publisher","DOI":"10.1016\/j.pep.2004.09.022"},{"key":"R75","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1028"},{"key":"R76","doi-asserted-by":"publisher","DOI":"10.1126\/science.1088166"},{"key":"R77","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-006-0465-8"},{"key":"R78","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.34091"},{"key":"R79","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-012-2144-4"},{"key":"R80","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.8(4)2015.16236"},{"key":"R81","doi-asserted-by":"publisher","DOI":"10.1038\/emm.1999.32"},{"key":"R82","first-page":"478","article-title":"Soluble recombinant endostatin purified from escherichia coli: Antiangiogenic activity and antitumor effect","volume":"61","author":"Huang X","year":"2001","journal-title":"Cancer Res"},{"key":"R83","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.3658"},{"key":"R84","doi-asserted-by":"publisher","DOI":"10.1006\/prep.2001.1585"},{"key":"R85","doi-asserted-by":"publisher","DOI":"10.1016\/j.pep.2004.09.021"},{"key":"R86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2008.04.024"},{"key":"R87","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.05.031"},{"key":"R88","doi-asserted-by":"publisher","DOI":"10.1007\/s12257-009-0100-5\u200f"},{"key":"R89","doi-asserted-by":"publisher","DOI":"10.1016\/j.procbio.2012.12.017\u200f"},{"key":"R90","doi-asserted-by":"publisher","DOI":"10.1042\/BA20090063"},{"key":"R91","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601745"},{"key":"R92","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1530"},{"key":"R93","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-04-0321"},{"key":"R94","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S21881"},{"key":"R95","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S14753"},{"key":"R96","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-10-0804"},{"key":"R97","first-page":"8758","article-title":"Lung cancer cellular apoptosis induced by recombinant human endostatin gold nanoshell-mediated near-infrared thermal therapy","volume":"8","author":"Luo H","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"R98","doi-asserted-by":"publisher","DOI":"10.5681\/apb.2014.074"},{"key":"R99","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S82029\u200f"},{"key":"R100","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-014-5818-0"},{"key":"R101","first-page":"4","article-title":"Expression systems for process and product improvement","volume":"6","author":"Rader RA","year":"2008","journal-title":"BioProcess Int"}],"container-title":["Advanced Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.tbzmed.ac.ir\/APB\/Manuscript\/APB-7-21.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T03:37:24Z","timestamp":1601955444000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.tbzmed.ac.ir\/APB\/Abstract\/APB_3562_20160609102343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,13]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,4]]}},"URL":"https:\/\/doi.org\/10.15171\/apb.2017.004","relation":{},"ISSN":["2228-5881","2251-7308"],"issn-type":[{"value":"2228-5881","type":"print"},{"value":"2251-7308","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,13]]}}}